Previous Close | 9.22 |
Open | 9.22 |
Bid | 9.23 x 100 |
Ask | 9.27 x 200 |
Day's Range | 9.21 - 9.66 |
52 Week Range | 8.82 - 21.00 |
Volume | |
Avg. Volume | 591,941 |
Market Cap | 1.475B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.63 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 25.25 |
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
The FDA places a clinical hold on Neumora's (NMRA) phase I study evaluating NMRA-266 for some types of neuropsychiatric disorders. Shares of the company fall on the news.